Shopping Cart
- Remove All
- Your shopping cart is currently empty
Sennidin A, has two hydroxyanthraquinone-like moieties, exerts inhibition on NS3 helicase with IC50 values of 0.8 μM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $165 | 35 days | |
10 mg | $735 | 35 days |
Description | Sennidin A, has two hydroxyanthraquinone-like moieties, exerts inhibition on NS3 helicase with IC50 values of 0.8 μM. |
In vitro | Here, we exploited the avidity of the Sennidin A (SA) tracer and radioiodinated SA (131I-SA) to necrotic tumors in order to further empower TNT. We showed high uptake and prolonged retention of SA in necrotic tumors and a quick clearance in other non-targeted tissues including the liver. On SPECT-CT images, tumor mass appeared persistently as a hotspot. Based on the prominent targetability of 131I-SA to the tumor necrosis, we designed a combinational theragnostic modality. The vascular disrupting agent (VDA) combretastatin A4 phosphate (CA4P) was used to cause massive tumor necrosis, which formed the target of 131I-SA that subsequently killed the residual tumor cells by cross-fire irradiation of beta particles. Consequently, 131I-SA combined with CA4P significantly inhibited tumor growth, extended tumor doubling time and prolonged mean animal survival[1] |
Molecular Weight | 538.46 |
Formula | C30H18O10 |
Cas No. | 641-12-3 |
Smiles | OC(c(cc1O)cc([C@H]([C@H](c2cccc(O)c22)c3cc(C(O)=O)cc(O)c3C2=O)c2c3c(O)ccc2)c1C3=O)=O |
Relative Density. | 1.695g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.